Marriott Harrison advises Beringea on its investment in Second Nature

Thursday 20th February, 2020

MH advised lead investor Beringea on its investment in OurPath (now rebranded as Second Nature), as part of the company’s $10 million Series A fundraising.

Second Nature aims to tackle the issues of diabetes and obesity, and the health tech start up is the first ‘lifestyle change program’ to be commissioned by the NHS for diabetes management.

The Marriott Harrison team was led by corporate partner David Strong and included Graham Halliday, Kerry Corrigan, Chris Mooney, Ed Belam, Alex Lee and Sofia Gottgens.